Generalized selection to overcome innate immunity selects for host breadth in an RNA virus

Evolution

Volumn 70, Issue 2, 2016, Pages 270-281

  Wasik, Brian R ^a,b   Muñoz Rojas, Andrés R ^c   Okamoto, Kenichi W ^a   Miller Jensen, Kathryn ^a,c   Turner, Paul E ^a  

^a YALE UNIVERSITY   (United States)

^b Cornell University ^*  (United States)

^c Yale University   (United States)

Author keywords

Emergence; Experimental evolution; Generalism; Host range; Interferon

Indexed keywords

CANCER; CELLS AND CELL COMPONENTS; EMERGENCE; EUKARYOTE; FITNESS; HOST RANGE; IMMUNE SYSTEM; PROTEIN; RNA; SELECTION; VIRUS;

EUKARYOTA; PRIMATES; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

ANIMAL; DOG; GENETIC SELECTION; GENETICS; HELA CELL LINE; HOST RANGE; HUMAN; INNATE IMMUNITY; MDCK CELL LINE; MOLECULAR EVOLUTION; VESICULOVIRUS;

ANIMALS; DOGS; EVOLUTION, MOLECULAR; HELA CELLS; HOST SPECIFICITY; HUMANS; IMMUNITY, INNATE; MADIN DARBY CANINE KIDNEY CELLS; SELECTION, GENETIC; VESICULOVIRUS;

EID: 84958185919     PISSN: 00143820     EISSN: 15585646     Source Type: Journal    
DOI: 10.1111/evo.12845     Document Type: Article

References (37)

1. Ahmed, M., M. O. McKenzie, S. Puckett, M. Hojnacki, L. Poliquin, and D. S. Lyles. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Viro 77:4646-4657.
2. Alto, B. W., B. R. Wasik, N. M. Morales, and P. E. Turner. 2013. Stochastic temperatures impede RNA virus adaptation. Evolution 67:969-979.
3. Barclay, V. C., D. A. Kennedy, V. C. Weaver, D. Sim, J. O. Lloyd-Smith, and A. F. Read. 2014. The effect of immunodeficiency on the evolution of virulence: an experimental test with the rodent malaria Plasmodium chabaudi*. Am. Nat. 184 (Suppl 1):S47-S57.
4. Bosch, T. C. G. 2013. Cnidarian-microbe interactions and the origin of innate immunity in metazoans. Ann. Rev. Microbiol. 67:499-518.
5. Carey, B. L., M. Ahmed, S. Puckett, and D. S. Lyles. 2008. Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus. J. Viro 82:12104-12115.
6. Cepica, A. and J. B. Derbyshire. 1986. The role of interferon in spontaneous cell-mediated cytotoxicity in pigs. Vet. Microbiol. 11:69-77.
7. Desmyter, J., J. L. Melnick, and W. E. Rawls. 1968. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J. Viro 2:955-961.
8. Duffy, S., L. A. Shackelton, and E. C. Holmes. 2008. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9:267-276.
9. Enoch, T., K. Zinn, and T. Maniatis. 1986. Activation of the human beta-interferon gene requires an interferon-inducible factor. Mol. Cell. Biol. 6:801-810.
10. Gayle, D., S. E. Ilyin, M. E. Miele, and C. R. Plata-Salamán. 1998. Modulation of TNF-α mRNA production in rat C6 glioma cells by TNF-α, IL-1β, IL-6, and IFN-α: In vitro analysis of cytokine-cytokine interactions. Brain Res. Bull. 47:231-235.
11. Grandvaux, N., B. R. tenOever, M. J. Servant, and J. Hiscott. 2002. The interferon antiviral response: from viral invasion to evasion. Curr Opin. Infectious Dis. 15:259-267.
12. Hamming, O. J., G. Lutfalla, J.-P. Levraud, and R. Hartmann. 2011. Crystal structure of Zebrafish interferons I and II reveals conservation of type I interferon structure in vertebrates. J. Viro 85:8181-8187.
13. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313-1318.
14. Horodyski, F. M., S. T. Nichol, K. R. Spindler, and J. J. Holland. 1983. Properties of DI particle resistant mutants of vesicular stomatitis virus isolated from persistent infections and from undiluted passages. Cell 33:801-810.
15. Howard, C. R. and N. F. Fletcher. 2012. Emerging virus diseases: can we ever expect the unexpected? Emerg. Microbes Infec 1:e46.
16. Lam, V., K. A. Duca, and J. Yin. 2005. Arrested spread of vesicular stomatitis virus infections in vitro depends on interferon-mediated antiviral activity. Biotechnol. Bioeng. 90:793-804.
17. Ludwig, S., C. Ehrhardt, E. R. Neumeier, M. Kracht, U. R. Rapp, and S. Pleschka. 2001. Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 276:10990-10998.
18. Mahalingam, S., J. Meanger, P. S. Foster, and B. A. Lidbury. 2002. The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses. J. Leuk. Biol. 72:429-439.
19. McFadden, G., M. R. Mohamed, M. M. Rahman, and E. Bartee. 2009. Cytokine determinants of viral tropism. Nat. Rev. Immunol. 9:645-655.
20. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449:819-826.
21. Miller-Jensen, K., K. A. Janes, J. S. Brugge, and D. A. Lauffenburger. 2007. Common effector processing mediates cell-specific responses to stimuli. Nature 448:604-608.
22. Miralles, R., P. J. Gerrish, A. Moya, and S. F. Elena. 1999. Clonal interference and the evolution of RNA viruses. Science 285:1745-1747.
23. Mushegian, A. and R. Medzhitov. 2001. Evolutionary perspective on innate immune recognition. J. Cell Biol. 155:705-710.
24. Novella, I. S., M. Cilnis, S. F. Elena, J. Kohn, A. Moya, E. Domingo, and J. J. Holland. 1996. Large-population passages of vesicular stomatitis virus in interferon-treated cells select variants of only limited resistance. J. Viro 70:6414-6417.
25. Park, M., C. Loverdo, S. J. Schreiber, and J. O. Lloyd-Smith. 2013. Multiple scales of selection influence the evolutionary emergence of novel pathogens. Phil. Trans. R. Soc. B 368:20120333.
26. R Core Team. 2015. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/.
27. Remold, S. 2012. Understanding specialism when the Jack of all trades can be the master of all. Proc. R Soc. Biol. Sci. 279:4861-4869.
28. Remold, S. K., A. Rambaut, and P. E. Turner. 2008. Evolutionary genomics of host adaptation in vesicular stomatitis virus. Mol. Biol. Evol. 25:1138-1147.
29. Reperant, L. A., T. Kuiken, B. T. Grenfell, and A. D. M. E. Osterhaus. 2014. The immune response and within-host emergence of pandemic influenza virus. Lancet Early Online Publication, doi:10.1016/S0140-6736(13)62425-3.
30. Sadler, A. J. and B. R. G. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
31. Takaoka, A., Z. Wang, M. K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501-505.
32. Turner, P. E. and S. F. Elena. 2000. Cost of host radiation in an RNA virus. Genetics 156:1465-1470.
33. Turner, P. E., N. M. Morales, B. W. Alto, and S. K. Remold. 2010. Role of evolved host breadth in the initial emergence of an RNA virus. Evolution 64:3273-3286.
34. von Kobbe, C., J. van Deursen, J. P. Rodrigues, D. Sitterlin, A. Bachi, X. Wu, M. Wilm, M. Carmo-Fonseca, and E. Izaurralde. 2000. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol. Cell 6:1243-1252.
35. Vossen, M. T. M., E. M. Westerhout, C. Söderberg-Nauclér, and E. J. H. J. Wiertz. 2002. Viral immune evasion: a masterpiece of evolution. Immunogenetics 54:527-542.
36. Wasik, B. R. and P. E. Turner. 2013. On the biological success of viruses. Ann. Rev. Microbiol. 67:519-541.
37. Woolhouse, M. E., L. H. Taylor, and D. T. Haydon. 2001. Population biology of multihost pathogens. Science 292:1109-1112.